For the quarter ending 2025-09-30, FBIOP has $181,407K in assets. $116,222K in debts. $86,218K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 86,218 | 74,386 | ||
| Accounts receivable, net | 17,983 | 15,644 | ||
| Inventory | 11,818 | 12,852 | ||
| Other receivables-Other Affiliates | 142 | 558 | ||
| Prepaid expenses and other current assets | 2,342 | 6,956 | ||
| Assets held for sale | 0 | 0 | ||
| Total current assets | 118,503 | 110,396 | ||
| Property, plant and equipment, net | 2,611 | 2,704 | ||
| Operating lease right-of-use asset, net | 12,321 | 12,817 | ||
| Restricted cash | 1,220 | 1,220 | ||
| Intangible assets, net | 28,670 | 29,734 | ||
| Other assets | 18,082 | 3,024 | ||
| Total assets | 181,407 | 159,895 | ||
| Accounts payable and accrued expenses | 45,171 | 48,576 | ||
| Income taxes payable | 1,005 | 984 | ||
| Common stock warrant liabilities | 2 | 0 | ||
| Operating lease liabilities, short-term | 2,129 | 2,140 | ||
| Partner company notes payable, short-term | 5,625 | 3,750 | ||
| Partner company installment payments - licenses, short-term | 0 | 0 | ||
| Other current liabilities | 135 | 2,071 | ||
| Total current liabilities | 54,067 | 57,521 | ||
| Notes payable, long-term, net | 47,774 | 50,026 | ||
| Operating lease liabilities, long-term | 12,765 | 13,303 | ||
| Other long-term liabilities | 1,616 | 1,662 | ||
| Total liabilities | 116,222 | 122,512 | ||
| Cumulative redeemable perpetual preferred stock, 0.001 par value, 15,000,000 authorized, 5,000,000 designated series a shares, 3,427,138 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively, liquidation value of 25.00 per share | 3 | 3 | ||
| Common stock, 0.001 par value, 200,000,000 shares authorized, 31,005,170 and 27,908,839 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 31 | 30 | ||
| Additional paid-in-capital | 785,943 | 779,856 | ||
| Accumulated deficit | -730,115 | -735,965 | ||
| Total stockholders' equity attributed to the company | 55,862 | 43,924 | ||
| Non-controlling interests | 9,323 | -6,541 | ||
| Total stockholders' equity (deficit) | 65,185 | 37,383 | ||
| Total liabilities and stockholders' equity (deficit) | 181,407 | 159,895 | ||
Fortress Biotech, Inc. (FBIOP)
Fortress Biotech, Inc. (FBIOP)